Current magnetic resonance imaging-based diagnostic strategies for prostate cancer

被引：5
作者：
Inoue, Toru [1 ]
Shin, Toshitaka [1 ,2 ]
机构：
[1] Oita Univ, Dept Urol, Fac Med, Oita, Japan
[2] Oita Univ, Fac Med, Dept Urol, Idaigaoka 1-1,Hasama Machi, Yufu, Oita 8795593, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2023年 / 30卷 / 12期
关键词：
clinically significant cancer; MRI; prostate cancer; targeted biopsy; MRI-TARGETED BIOPSY; SYSTEM; ACCURACY; MODEL;
D O I：
10.1111/iju.15281
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Recent developments in multiparametric MRI and MRI-targeted biopsy have made it possible to detect clinically significant cancers more accurately and efficiently than ever before. Furthermore, software that enables easy MRI/US image fusion has been developed and is already available on the market, and this has provided a tailwind for the spread of MRI-based prostate cancer diagnostic strategies. Such precise diagnosis of prostate cancer localization is essential for highly accurate focal therapy. In addition, a recent large-scale study applying MRI to community screening for prostate cancer has reported its usefulness. By contrast, concerns about overdiagnosis and overtreatment, the existence of inter-reader variability in MRI diagnosis, and issues with current MRI-targeted biopsy have emerged. In this article, we review the development of multiparametric MRI and MRI-targeted biopsy to date and the current issues and discuss future directions.
引用
收藏
页码：1078 / 1086
页数：9
相关论文
共 55 条
  • [21] Techniques and Outcomes of MRI-TRUS Fusion Prostate Biopsy
    Kaneko, Masatomo
    Sugano, Dordaneh
    Lebastchi, Amir H.
    Duddalwar, Vinay
    Nabhani, Jamal
    Haiman, Christopher
    Gill, Inderbir S.
    Cacciamani, Giovanni E.
    Abreu, Andre Luis
    [J]. CURRENT UROLOGY REPORTS, 2021, 22 (04)
  • [22] MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
    Kasivisvanathan, V
    Rannikko, A. S.
    Borghi, M.
    Panebianco, V
    Mynderse, L. A.
    Vaarala, M. H.
    Briganti, A.
    Budaus, L.
    Hellawell, G.
    Hindley, R. G.
    Roobol, M. J.
    Eggener, S.
    Ghei, M.
    Villers, A.
    Bladou, F.
    Villeirs, G. M.
    Virdi, J.
    Boxler, S.
    Robert, G.
    Singh, P. B.
    Venderink, W.
    Hadaschik, B. A.
    Ruffion, A.
    Hu, J. C.
    Margolis, D.
    Crouzet, S.
    Klotz, L.
    Taneja, S. S.
    Pinto, P.
    Gill, I
    Allen, C.
    Giganti, F.
    Freeman, A.
    Morris, S.
    Punwani, S.
    Williams, N. R.
    Brew-Graves, C.
    Deeks, J.
    Takwoingi, Y.
    Emberton, M.
    Moore, C. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19) : 1767 - 1777
  • [23] Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis
    Kasivisvanathan, Veeru
    Stabile, Armando
    Neves, Joana B.
    Giganti, Francesco
    Valerio, Massimo
    Shanmugabavan, Yaalini
    Clement, Keiran D.
    Sarkar, Debashis
    Philippou, Yiannis
    Thurtle, David
    Deeks, Jonathan
    Emberton, Mark
    Takwoingi, Yemisi
    Moore, Caroline M.
    [J]. EUROPEAN UROLOGY, 2019, 76 (03) : 284 - 303
  • [24] Comparison of Prostate Imaging Reporting and Data System Versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3+4=7 Cancers
    Krishna, Satheesh
    McInnes, Matthew
    Lim, Christopher
    Lim, Robert
    Hakim, Shaheed W.
    Flood, Trevor A.
    Schieda, Nicola
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (06) : W365 - W373
  • [25] Multifocality and Prostate Cancer Detection by Multiparametric Magnetic Resonance Imaging: Correlation with Whole-mount Histopathology
    Le, Jesse D.
    Tan, Nelly
    Shkolyar, Eugene
    Lu, David Y.
    Kwan, Lorna
    Marks, Leonard S.
    Huang, Jiaoti
    Margolis, Daniel J. A.
    Raman, Steven S.
    Reiter, Robert E.
    [J]. EUROPEAN UROLOGY, 2015, 67 (03) : 569 - 576
  • [26] Meissner Valentin H, 2022, Eur Urol, V82, P156, DOI 10.1016/j.eururo.2021.11.019
  • [27] The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years
    Meng, Xiaosong
    Rosenkrantz, Andrew B.
    Huang, Richard
    Deng, Fang-Ming
    Wysock, James S.
    Bjurlin, Marc A.
    Huang, William C.
    Lepor, Herbert
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2018, 200 (05) : 1022 - 1028
  • [28] Cancer detection rates of the PI-RADSv2.1 assessment categories: systematic review and meta-analysis on lesion level and patient level
    Oerther, Benedict
    Engel, Hannes
    Bamberg, Fabian
    Sigle, August
    Gratzke, Christian
    Benndorf, Matthias
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (02) : 256 - 263
  • [29] Which Patients with Negative Magnetic Resonance Imaging Can Safely Avoid Biopsy for Prostate Cancer?
    Oishi, Masakatsu
    Shin, Toshitaka
    Ohe, Chisato
    Nassiri, Nima
    Palmer, Suzanne L.
    Aron, Manju
    Ashrafi, Akbar N.
    Cacciamani, Giovanni E.
    Chen, Frank
    Duddalwar, Vinay
    Stern, Mariana C.
    Ukimura, Osamu
    Gill, Inderbir S.
    Abreu, Andre Luis de Castro
    [J]. JOURNAL OF UROLOGY, 2019, 201 (02) : 268 - 276
  • [30] Combination of MRI prostate and 18F-DCFPyl PSMA PET/CT detects all clinically significant prostate cancers in treatment-naive patients: An international multicentre retrospective study
    Parathithasan, Nishanthinie
    Perry, Elisa
    Taubman, Kim
    Hegarty, Justin
    Talwar, Arpit
    Wong, Lih-Ming
    Sutherland, Tom
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2022, 66 (07) : 927 - 935
123456